4.7 Article

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study

Journal

ALZHEIMERS & DEMENTIA
Volume 14, Issue 3, Pages 280-292

Publisher

WILEY
DOI: 10.1016/j.jalz.2017.09.007

Keywords

Vascular cognitive impairment; Vascular dementia; Guidelines; Criteria; consensus; Delphi

Funding

  1. Alzheimer's Society (UK) [Ref117]
  2. Pfizer
  3. Athersys
  4. AstraZeneca
  5. Lundbeck
  6. Cerevast
  7. Daiichi Sankyo
  8. Boehringer Ingelheim
  9. GE Healthcare
  10. TauRx
  11. Cytox
  12. Avid/Lilly
  13. Takeda
  14. Eli Lilly
  15. Elan/Transition Therapeutics
  16. Roche
  17. Cognoptix
  18. Eisai
  19. Novartis
  20. Alzheimers Research UK [ARUK-PG2013-22] Funding Source: researchfish
  21. Alzheimer's Society [117] Funding Source: researchfish
  22. Medical Research Council [G0900652, MR/L023784/1, G0502157, G0400074, G0500247, G1100540] Funding Source: researchfish
  23. MRC [G0400074, G0502157, MC_PC_18025, G0900652, G1100540, MR/M024784/1, G0500247, MR/L023784/1, MC_PC_14095] Funding Source: UKRI

Ask authors/readers for more resources

Introduction: Progress in understanding and management of vascular cognitive impairment (VCI) has been hampered by lack of consensus on diagnosis, reflecting the use of multiple different assessment protocols. A large multinational group of clinicians and researchers participated in a two-phase Vascular Impairment of Cognition Classification Consensus Study (VICCCS) to agree on principles (VICCCS-1) and protocols (VICCCS-2) for diagnosis of VCI. We present VICCCS-2. Methods: We used VICCCS-1 principles and published diagnostic guidelines as points of reference for an online Delphi survey aimed at achieving consensus on clinical diagnosis of VCI. Results: Six survey rounds comprising 65-79 participants agreed guidelines for diagnosis of VICCCS-revised mild and major forms of VCI and endorsed the National Institute of Neurological Disorders-Canadian Stroke Network neuropsychological assessment protocols and recommendations for imaging. Discussion: The VICCCS-2 suggests standardized use of the National Institute of Neurological Disorders-Canadian Stroke Network recommendations on neuropsychological and imaging assessment for diagnosis of VCI so as to promote research collaboration. (C) 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available